Integrated Diagnostics Earnings Estimate

IDHC Stock   0.40  0.02  5.26%   
By analyzing Integrated Diagnostics' earnings estimates, investors can diagnose different trends across Integrated Diagnostics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Integrated Diagnostics Holdings is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
Integrated Diagnostics is projected to generate 0.347625 in earnings per share on the 31st of December 2024. Integrated Diagnostics earnings estimates module stress-tests analyst consensus about projected Integrated Diagnostics Holdings EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Integrated Diagnostics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Integrated Diagnostics' earnings estimates, investors can diagnose different trends across Integrated Diagnostics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to drop to about 1.1 B in 2024
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Integrated Diagnostics Earnings per Share Projection vs Actual

About Integrated Diagnostics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Integrated Diagnostics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Integrated Diagnostics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Integrated Diagnostics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings1.3 B1.4 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Integrated Stock Analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.